Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Suven Life gets patents for neuro-degenerative drug

      Suven Life gets patents for neuro-degenerative drug

      savita thakur thakur13 July 2016 2:03 PM IST
      New Delhi : Drug firm Suven Life Sciences has been granted a patent each by India and South Africa for a drug used in treatment of neuro-degenerative...
      Opto Circuits to launch new catheter for dialysis patients

      Opto Circuits to launch new catheter for dialysis patients

      savita thakur thakur13 July 2016 2:02 PM IST
      New Delhi : Medical devices firm Opto Circuits Germany-based subsidiary Eurocor will launch coated shunt balloon catheter used for patients undergoing...
      FDA approves first MRI-guided focused ultrasound device to treat essential tremor

      FDA approves first MRI-guided focused ultrasound device to treat essential tremor

      savita thakur thakur12 July 2016 1:45 PM IST
      The U.S. Food and Drug Administration approved the first focused ultrasound device to treat essential tremor in patients who have not responded to...
      Novartis copy of Amgen arthritis drug highly similar: FDA staff

      Novartis copy of Amgen arthritis drug highly similar: FDA staff

      savita thakur thakur12 July 2016 11:55 AM IST
      Novartis AG's cheaper version of Amgen Inc's blockbuster arthritis drug Enbrel is highly similar in potency and safety to the original, according to a...
      Zydus Cadila gets USFDA nod for diabetes treatment drug

      Zydus Cadila gets USFDA nod for diabetes treatment drug

      savita thakur thakur12 July 2016 11:54 AM IST
      New Delhi : Drug firm Zydus Cadila has received final approval from the US health regulator to market Nateglinide tablets, used for treatment of...
      China healthcare costs forcing patients into crippling debt

      China healthcare costs forcing patients into crippling debt

      savita thakur thakur11 July 2016 3:19 PM IST
      London : As China's medical bills rise steeply, outpacing government insurance provision, patients and their families are increasingly turning to...
      E-commerce helping easy availability of pharma drugs and abuse

      E-commerce helping easy availability of pharma drugs and abuse

      savita thakur thakur11 July 2016 2:29 PM IST
      New Delhi : Growing e-commerce in India is facilitating significant increase in online pharmacies, leading to easy availability of pharmaceutical...
      Novartis announces FDA approval of Xolair® (omalizumab) for pediatric allergic asthma

      Novartis announces FDA approval of Xolair® (omalizumab) for pediatric allergic asthma

      savita thakur thakur11 July 2016 2:27 PM IST
      Novartis announced that the US Food and Drug Administration (FDA) has approved an expanded age range for Xolair® (omalizumab) to include children six...
      USFDA finds minor violations at Lupins Dabhasa plant

      USFDA finds minor violations at Lupin's Dabhasa plant

      savita thakur thakur10 July 2016 4:10 PM IST
      New Delhi : Drug firm Lupin said US health regulator has voiced minor concerns after completing the inspection of its Dabhasa facility in...
      Cadila Healthcare gets EIR from USFDA for Moraiya facility

      Cadila Healthcare gets EIR from USFDA for Moraiya facility

      savita thakur thakur10 July 2016 4:06 PM IST
      New Delhi : Drug firm Cadila Healthcare has received Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility...
      Cipla to invest Rs 590 crore for a biosimilars plant in South Africa

      Cipla to invest Rs 590 crore for a biosimilars plant in South Africa

      savita thakur thakur10 July 2016 4:06 PM IST
      New Delhi : Drug firm Cipla will invest around Rand 1.3 billion (over Rs 590 crore) to launch a manufacturing facility in South Africa for the...
      Amgen drug appears highly similar to Humira: FDA staff

      Amgen drug appears highly similar to Humira: FDA staff

      savita thakur thakur10 July 2016 4:05 PM IST
      Amgen Inc's version of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, appears similar in potency and safety to the original...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok